Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non‑microdosers

Key Points

• Microdosers report significantly lower levels of anxiety and depression than non-microdosers, highlighting potential therapeutic effects.
• The analysis involves self-reported health-related motivations for microdosing, indicating that mental wellness is a priority for participants.
• Assessment of psychological outcomes reveals a notable correlation between microdosing and improved mental health metrics over time.
• Potential mental health benefits may indicate the therapeutic use of psychedelics, emphasizing the need for further investigation on long-term effects.